GENETIC POLYMORPHISM OF CYP2B6 AFFECTS THE PHARMACOKINETICS OF SIBUITRAMINE'S METABOLITE

被引：0
|
作者：
Cho, M. S. [1 ]
Jang, S. [1 ]
Lee, Y. [1 ]
Lim, L. [1 ]
Park, K. [1 ]
Chung, J. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [1] Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane
    D'Avolio, Antonio
    De Francia, Silvia
    Basile, Vittoria
    Cusato, Jessica
    De Martino, Francesca
    Pirro, Elisa
    Piccione, Francesca
    Ardito, Arianna
    Zaggia, Barbara
    Volante, Marco
    Di Perri, Giovanni
    Terzolo, Massimo
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (06): : 293 - 300
  • [2] ROLE OF CYP2B6 POLYMORPHISM IN THE METABOLISM AND PHARMACOKINETICS OF METHADONE ENANTIOMERS
    Somogyi, A. A.
    Coller, J. K.
    Foster, D. B. F.
    Li, Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 32 - 32
  • [3] Pharmacokinetics of Plasma Efavirenz and CYP2B6 Polymorphism in Southern Chinese
    To, Kin Wang
    Liu, Shui Teng
    Cheung, Siu Wai
    Chan, D. Pui Chung
    Chan, R. Chiu Yeung
    Lee, Shui Shan
    THERAPEUTIC DRUG MONITORING, 2009, 31 (04) : 527 - 530
  • [4] Impact of CYP2B6 polymorphism on the pharmacokinetics and clinical response of subjects receiving methadone
    Victorri-Vigneau, Caroline
    Verstuyft, Celine
    Laforgue, Edouard
    Bouquie, Regis
    Hardouin, Jean-Benoit
    Leboucher, Juliette
    Challet-Bouju, Gaelle G.
    Grall-Bronnec, Marie
    THERAPIE, 2018, 73 (06): : 563 - 563
  • [5] Effect of genetic polymorphism of human CYP2B6 on the metabolic activation of chlorpyrifos
    Imaishi, Hiromasa
    Goto, Tatsushi
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2018, 144 : 42 - 48
  • [6] Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics
    Saiz-Rodriguez, Miriam
    Ochoa, Dolores
    Roman, Manuel
    Zubiaur, Pablo
    Koller, Dora
    Mejia, Gina
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2020, 21 (10) : 663 - 675
  • [7] Population Differences in the Genetic Polymorphism of CYP2B6 May Impact on the Pharmacology of MMT
    Nurfadhlina, M.
    Nasir, M.
    Darussalam, B.
    Azhar, M. Y. M.
    Tan, S. C.
    Ismail, R.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 12 - 12
  • [8] CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
    Mango, Katalin
    Kiss, Adam Ferenc
    Fekete, Ferenc
    Erdos, Reka
    Monostory, Katalin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [9] CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
    Katalin Mangó
    Ádám Ferenc Kiss
    Ferenc Fekete
    Réka Erdős
    Katalin Monostory
    Scientific Reports, 12
  • [10] Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6
    Kirchheiner, J
    Klein, C
    Meineke, I
    Sasse, J
    Zanger, UM
    Mürdter, TE
    Roots, I
    Brockmöller, J
    PHARMACOGENETICS, 2003, 13 (10): : 619 - 626
12345